Bioterrorism Agents Epidemiology Program Overview.

Slides:



Advertisements
Similar presentations
Responding to the Threat of Bioterrorism: A Status Report on Vaccine Research in the United States Good Morning. Over the next 1 ½ hours of so I’ll be.
Advertisements

Plague CDC, AFIP. Diseases of Bioterrorist Potential Learning Objectives Describe the epidemiology, mode of transmission, and presenting symptoms of disease.
Northwest Center for Public Health Practice University of Washington School of Public Health and Community Medicine 1 Preparing for and Responding to Bioterrorism:
Developed by SHS Science Department
BIOLOGICAL AGENTS  CDC has prioritized them in Lists A - C  A List:  Easily transmitted/disseminated  High mortality rate  Potential for public panic.
Bioterroism1 Biomed BCT. Bioterroism2 3 The first well-documented use of smallpox as a biological weapon was by British troops in the French and Indian.
By: Samantha Hatfield & Rachel Irwing. A severe lung infection that affects humans and animals.
Yersinia pestis Bubonic Plague By: Andrea Robertson Septicemic Plague
Microbes as Bioweapons
Any of the following risk factors within 3 weeks (21 days) before onset of symptoms 1,2 : Contact with blood or other body fluids of a patient known to.
Any of the following risk factors within 3 weeks (21 days) before onset of symptoms 1,2 : Contact with blood or other body fluids of a patient known to.
Bioterrorist Agents: Tularemia
Rash Illness Evaluation
The Science of Agroterrorism Bob L. Larson, DVM, PhD, ACPVM University Extension, Commercial Agriculture Program, Beef Focus Team University of Missouri,
Bioterrorism Agents: Plague Lesson 1 Introduction and Overview.
ANTHRAX By: Justin Tursellino. Anthrax is a…. Anthrax is an infection caused by a bacterium, Bacillus anthracis. The infection can take three forms depending.
Viral Hemorrhagic Fevers CDC, AFIP. Viral Hemorrhagic Fevers Diverse group of illnesses caused by RNA viruses from 4 families: –Arenaviridae, Bunyaviridae,
Discovering the World of Viral Hemorrhagic Fevers By Christy Leaman.
INFECTION CONTROL/EXPANDED PRECAUTIONS  In addition to standard precautions, Ambercare personnel will follow strict specifications when caring for patients.
EBOLA Virus Disease August 22, What is Ebola Virus Disease (EVD)? Ebola virus disease (also known as Ebola hemorrhagic fever) is a severe, often-fatal.
Outbreak Investigation: The First 48 Rachel Radcliffe, DVM, MPH Career Epidemiology Field Officer Division of Infectious Disease Epidemiology West Virginia.
THE BLACK PLAGUE. The Italian writer Boccaccio said the Plague’s victims often… "ate lunch with their friends and dinner with their ancestors in paradise."
Seasonal Influenza and Swine-Origin Influenza A (H1N1) Virus
Overview of Terrorism Research at the CDC Dixie E. Snider, M.D., MPH. Associate Director for Science Presented at 2003 Medical Research Summit March 6,
27/9/2010Definitions in Epidemiology (Dr. Salwa Tayel) 1.
Introduction to Tickborne Diseases
HUMAN HEALTH & ENVIRONMENTAL RISKS
Bioterrorism Agents – Plague Lesson 7 Information for Veterinarians.
Bioterrorism MLAB 2434: Microiology Keri Brophy-Martinez.
Bioterrorism Readiness Plan Shands Hospital at the University of Florida 2001.
Bioterrorism Readiness Plan Shands Hospital at the University of Florida 2001.
Epidemiology and Public Health Nester Chapter 20 Notebook, Page 281.
The Black Death.
Local Emergency Response to Biohazardous Incidents Dr. Elizabeth Whalen, MD Medical Director Albany County Health Department April 8, 2005 Northeast Biological.
BW Agents: Tularemia J.A. Sliman, MD, MPH LCDR MC(FS) USN Preventive Medicine Resident Johns Hopkins Bloomberg School of Public Health.
U3L2 Presentations Page 164 What to do questions What Did You Find Out questions 1 and 3.
Responding to SARS John Watson Health Protection Agency Communicable Disease Surveillance Centre, London.
By: Brittany Horan Large, aerobic, gram-positive, non- motile, encapsulated, chain forming, rod shaped that form oval spores. It is a bacterium of the.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
Case 7: “Pesteng Lamok”. “PESTENG LAMOK”  A 7 year old male child has been having fever (maximum 39 0 C) for the past 4 days.This was associated with.
SARS. What is SARS? Severe Acute Respiratory Syndrome Respiratory illness Asia, North America, and Europe Previously unrecognized coronavirus.
Port In Peril The following slides represent a realistic public health crisis event and you are charged with developing first messages for the public.
1 Biological Agents Slides will automatically advance seconds after clicking on start button.
BIOTERRORISM June 15, 2006 Christina M. Cabott D.O.
11 11/16/2015 Filo Viruses Hugh B. Fackrell Filename: Filovir.ppt.
15 minutes could save you 15% on car insurance This Presentation has been brought to you by Geico!
Severe acute respiratory syndrome. SARS. SARS is a communicable viral disease caused by a new strain of coronavirus. The most common symptoms in patient.
CDC Centers for Disease Control and Prevention Public Health &Bioterrorism European Diploma Course in Disaster Medicine Republic of San Marino 12 May,
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
Submitted by: Susan Henry Keith Noble
PU 430 Unit 5 Chapters 2 and 3. Bioterrorism Chapter Two.
By: David Gonzales. What is Bioterrorism?  A bioterrorism attack is the deliberate release of viruses, bacteria, toxins or other harmful agents used.
NURSING IN THE ERA OF BIOTERRORISM NURSING IN THE ERA OF BIOTERRORISM.
Bioterrorism. Goals and Objectives  What is bioterrorism?  What are the biological agents of terror?  What’s my role?
Patient with Ebola Hemorrhagic Fever, Bumba Zone, Equateur Province, DR Congo (Zaire), October 1976.
August 2005 EMS & Trauma Systems Section Office of Public Health Preparedness BIOLOGICAL AGENTS.
BIOTERRORISM: A PRIMER
VIRAL HAEMORRHAGIC FEVERS
Infection Control and Standard Precautions
Bioterrorism Agents: Plague
Blood and lymphatic infections
Biological agents that might be used as weapons of Bioterrorism
Francisella tularensis
Biological Terrorism Smallpox 5/9/01.
Phase 1 Phase 2 Phase 3 Phase 4 Phase 5 Phase 6 Cutaneous Inhalation
Yersinia Dr . Salma.
BW Agents: Plague J.A. Sliman, MD, MPH LCDR MC(FS) USN
University of Washington
Presentation transcript:

Bioterrorism Agents Epidemiology Program Overview

Bioterrorism Background Deliberate release of viruses, bacteria or other germs May be difficult to detect May not cause immediate illness Separated into three categories by CDC Category A Category B Category C

High Priority Agents Category A Easily spread; high death rates Anthrax, botulism, plague, smallpox, tularemia, and selected hemorrhagic fever viruses Category B Moderately easy to disseminate Brucellosis, food safety threats, Q fever, and other agents Category C Could be engineered for mass dissemination Emerging infectious diseases

Category A Bioterrorism Agents Agent Clinical Manifestations Communicability Anthrax Cutaneous, Inhalation, Gastrointestinal Not person-to-person Botulism Foodborne, Infant, Wound, Inhalation Not person-to-person Plague Bubonic, Pneumonic, Septicemic Droplet (pneumonic) Smallpox Ordinary, modified, flat, hemorrhagic Airborne, droplet, direct contact Tularemia Glandular, Septicemic, Oropharyngeal, Intestinal, Typhoidal, Pneumonic Not person-to-person Viral Hemorrhagic Fevers Filoviruses and Arenaviruses Airborne +, droplet, contact

Anthrax Infection through contact with infected animals/animal products or intentional exposure Possible indicators of bioterrorism Severe acute febrile disease with fulminant course and death Gram-positive bacilli in skin biopsy, blood smears, CSF Chest radiographs showing widened mediastinum

Botulism Occurrence Single cases occur sporadically Foodborne botulism – 1 VA case reported in 2007 Public health staff coordinate receipt of antitoxin Possible indicators of bioterrorism: Outbreak of multiple cases of descending, flaccid paralysis; Outbreak with unusual toxin type (e.g., C, D, F, G or type E not acquired from aquatic food) Outbreak with common geographic features but without common dietary exposure Multiple simultaneous outbreaks with no common source

Plague Caused by the bacterium Yersinia pestis Infection through bite of infected fleas, close contact with infected animals; inhalation of infective aerosols Possible indicators of bioterrorism: Cases in locations without enzootic infection Cases in persons without known risk factors (e.g., travel history, exposure to rodents/fleas) Sudden outbreak of illness in patients presenting with severe pneumonia and sepsis

Smallpox High risk of smallpox: Febrile prodrome, and Classic smallpox lesions, and Lesions in the same stage of development Moderate risk of smallpox: Febrile prodrome plus: One other high-risk criteria or Four or more of the following: Centrifugal distribution of lesions; First lesions in pharynx or oral mucosa; Patient appears toxic; Slow evolution of rash; Lesions on the palms and soles

Smallpox If moderate or high-risk for smallpox: Rapidly report to DSI and communicate with other programs (EP&R, OCOM) Collect information on CDC worksheet: Evaluating Patients for Smallpox osis/pdf/spox-patient-eval-wksheet.pdf Coordinate specimen collection/submission to DCLS Make infection control recommendations Consider activation of Smallpox Response Plan

Tularemia Occurrence About 200 cases/year in the U.S. 1 case reported in Virginia in 2010; Several in 2011 Possible indicators of bioterrorism: Increase in cases of acute, febrile illness Cases progressing to pharyngitis, bronchiolitis, pneumonitis, pleuritis, hilar lymphadenitis Laboratory findings: Small, gram-negative coccobacilli

Viral Hemorrhagic Fevers (VHF) Caused by several families of viruses Filoviruses (Ebola, Marburg) Arenaviruses (Lassa, Machupo) Infection through contact with rodents (Lassa, Machupo); animal hosts for Ebola and Marburg unknown; person-to-person Clinical presentation Fever; fatigue; dizziness; rash; myalgias; bleeding; shock; multi-organ failure

VHF and Bioterrorism Patients without relevant travel history and exposure Suspected index case: Temperature >101 F for less than three weeks; Severe illness; At least two of the following: hemorrhagic or purpuric rash, epistaxis, hematemesis, hemoptysis, blood in stool, or other hemorrhagic signs/symptoms; and No predisposing factors for hemorrhagic manifestations

Category A Agents Public Health Response Rapidly reportable Require immediate public health follow-up Consult with DSI and coordinate/communicate with EP&R and OCOM Collect information on relevant Case Report Forms Coordinate collection/submission of specimens to DCLS Make infection control recommendations Respiratory form of the diseases = consider BT May see naturally occurring cases Botulism: infant/foodborne Bubonic/pneumonic plague in those with travel and exposure history in western states Tularemia: Exposure to rabbits, ticks

Category B Agents Public Health Response Laboratory Reports from Private Labs Q Fever Brucella species Follow-up: Collect information on patient’s symptoms, why the test was ordered, evaluate possible exposures, consider confirmatory testing at DCLS. Record information on relevant Case Report Forms. Ensure that isolates are forwarded to DCLS